Chapter 10. Tobacco and Cardiovascular Disease: Achieving Smoking Cessation in Cardiac Patients

  1. Salim Yusuf DPhil, FRCPC, FRSC Research Chair Professor of Medicine Director Vice President Research2,3,4,
  2. John A Cairns MD, FRCPC Professor of Medicine Former Dean5,
  3. A John Camm MD British Heart Foundation Professor Head of Cardiac6,
  4. Ernest L Fallen MD, FRCPC Professor Emeritus7 and
  5. Bernard J Gersh MB, ChB, DPhil Consultant Professor of Medicine8
  1. Andrew Pipe CM, MD Professor Chief

Published Online: 21 MAY 2010

DOI: 10.1002/9781444309768.ch10

Evidence-Based Cardiology, Third Edition

Evidence-Based Cardiology, Third Edition

How to Cite

Pipe, A. (2009) Tobacco and Cardiovascular Disease: Achieving Smoking Cessation in Cardiac Patients, in Evidence-Based Cardiology, Third Edition (eds S. Yusuf, J. A. Cairns, A. J. Camm, E. L. Fallen and B. J. Gersh), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444309768.ch10

Editor Information

  1. 2

    McMaster University, Canada

  2. 3

    Population Health Research Institute, McMaster University, Hamilton Health Sciences, Canada

  3. 4

    Hamilton Health Sciences, Hamilton, Ontario, Canada

  4. 5

    Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  5. 6

    St George's University of London, London, UK

  6. 7

    McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada

  7. 8

    Mayo Clinic College of Medicine, Rochester, MN, USA

Author Information

  1. Faculty of Medicine, University of Ottawa, Division of Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Publication History

  1. Published Online: 21 MAY 2010
  2. Published Print: 13 NOV 2009

ISBN Information

Print ISBN: 9781405159258

Online ISBN: 9781444309768



  • cardiovascular disease;
  • mortality;
  • epidemiology;
  • tobacco smoking;
  • tobacco cessation


Cigarette smoking and other forms of tobacco use impose a large and growing global public health burden. Hundreds of millions of premature tobacco deaths could be avoided if effective interventions are widely applied worldwide in all countries. There is robust evidence that tobacco tax increases, timely dissemination of information about the health risks from smoking, restrictions on smoking in public and work places, comprehensive bans on advertising and promotion, and increased access to cessation therapies are effective in reducing tobacco use and its consequences. Cessation by the 1.1 billion current smokers is central to meaningful reductions in tobacco deaths over the next five decades. Reduced uptake of smoking by children would yield the benefits chiefly after 2050. Price and nonprice interventions are, for the most part, highly cost-effective.